About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Jan 27, 2020 1:24 pm | Biotechnology
Early in January 2019, Bristol-Myers Squibb’s (NYSE: BMY) $74 billion acquisition of Celgene Corporation dominated the headlines. But despite that big deal, 2019 was a rather lackluster year for the Biotechnology sector. However, the opening quarter of 2020 is... Read More »
by Dylan Sammut | Jan 20, 2020 2:21 pm | Home Health & Hospice
In October 2019, The Ensign Group (NASDAQ: ENSG) and The Pennant Group, Inc. (NASDAQ: PNTG) announced the completion of Pennant’s spin-off. The two separated to give investors more and better industry-specific options; The Ensign Group will stay focused on... Read More »
by Dylan Sammut | Jan 20, 2020 1:07 pm | eHealth
The eHealth sector hit the ground running in 2020. In the first two and a half weeks 15 eHealth transactions have been announced, and we expect it to easily eclipse January 2019’s deal volume of 16. It’s already matched last month’s total count of... Read More »
by Dylan Sammut | Jan 20, 2020 10:59 am | Healthcare Market Updates
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see... Read More »
by Dylan Sammut | Jan 13, 2020 4:27 pm | Home Health & Hospice
Arosa+LivHOME is already on the acquisition trail in the new year. According to our Deal Search Online database, the company reported six transactions in 2019 and is wasting no time to keep growing. In early January, the Bain Capital Double Impact portfolio company... Read More »